New Zealand’s standalone infant formula standard takes effect

New Zealand's standalone infant formula standard takes effect

Summary

In August 2024, New Zealand formally announced it would not adopt the revised Australia New Zealand Food Standards Code Standard 2.9. 1 – Infant Formula Products, and decided to develop its own infant formula standard. The New Zealand Infant Formula Standard 2026 was officially published on 22 September 2026 and came into force on 25 September 2026, marking the formal implementation of a dedicated infant formula standard for New Zealand.

The standard covers infant formula, follow-on formula and food for special medical purposes for infants. Infant formula is primarily for infants aged 0–6 months, while follow-on formula is primarily for infants aged 6–12 months. The new standard largely adopts most requirements of the latest revision of the Australia New Zealand Code Standard 2.9.

1, with adjustments only to provisions on protein source declarations, nutrition information declarations, the prescribed form of nutrition information declarations and prohibited label claims, and adds a new section on permitted additional label claims. During the transition period, infant formula sold in New Zealand may comply with either the 20240912 version of the Australia New Zealand Code Standard 2.9. 1 or the New Zealand Infant Formula Standard 2026.

From 14 September 2029, mandatory enforcement begins and the 20240912 version will no longer serve as a basis for compliance in the New Zealand market. On label differences, the new New Zealand standard replaces four provisions and adds one exclusive claims rule: food names must not include information about A2-type beta-casein, but additional claims may be made elsewhere on the label under clause 1.9; nutrition information declarations now permit voluntary declaration of A1 or A2 beta-casein content, provided total casein content is also declared; products declaring A1 or A2 beta-casein content must use the format in Schedule 1 of the new standard, while those not making such declarations may continue to use the format in Schedule 29–10 of the Australia New Zealand Food Standards Code.

Commentary

The implementation of New Zealand's standalone infant formula standard marks a substantive divergence in the joint Australia-New Zealand food standards system for infant formula. For local small and medium-sized enterprises, this regulatory difference is both a compliance challenge and an opportunity for differentiated competition. The new standard sets clear restrictions on A2-type beta-casein claims on labels: food names must not include A2-related information, but additional claims may be made elsewhere on the label, provided total casein content is also declared.

This adjustment directly responds to the recent popularity of the A2 protein concept in the infant formula market and reflects New Zealand regulators' attention to claim truthfulness and consumers' right to information. Against the industry backdrop, New Zealand is a globally important dairy exporter, and infant formula is a higher-value-added category, but the local market is limited in size and most manufacturers rely on exports. Under the previous joint Australia-New Zealand standard, companies needed only one set of labels to cover both markets; with the new standard, products for the New Zealand market require separately designed labels, increasing compliance costs.

However, the new standard allows voluntary declaration of A1 or A2 beta-casein content, providing a compliance pathway for brands that highlight A2 protein as a selling point, while requiring simultaneous declaration of total casein to avoid misleading consumers. For New Zealand SME owners, if products involve infant formula exports or local sales, they should assess as soon as possible whether existing labels comply with the new standard, particularly given the transition period runs until 14 September 2029, during which either the old or new standard may be used, but switching timelines need to be planned in advance. At the same time, they should monitor whether Australia follows with similar adjustments; if Australia maintains its original standard, label differences between the Australian and New Zealand markets will persist, and companies will need to establish two label management systems.

In addition, the new standard imposes stricter requirements on protein source declarations, prohibiting the use of the generic term 'milk' in food names and requiring clear indication of plant or animal origin, which helps improve product transparency but may affect some marketing strategies that rely on vague claims. From a broader perspective, New Zealand's move may affect its long-term cooperation with Australia on food standard harmonisation, but the short-term impact on trade flows is limited, because infant formula exports mainly target third markets such as China, and local label adjustments will not change core formulations and quality. SMEs should use the transition period to work with label design agencies and compliance consultants to ensure label updates are completed before mandatory enforcement, while also paying attention to the new standard's additional requirements for food for special medical purposes for infants to avoid product withdrawals caused by overlooked details.

Keywords: infant formula standard, New Zealand, Australia New Zealand Food Standards Code, transition period, A2-type beta-casein, nutrition information declaration, protein source declaration, label claims, effective 25 September 2026


Photo by Parth Patel on Pexels

Source: tangjiu.cn

Disclaimer: This article is compiled from publicly available sources for general information only. The analysis and commentary are editorial opinions. MiDeer Observer does not guarantee the accuracy or completeness of the information provided. Readers should seek independent professional advice before relying on this content, or contact us for more information.